We are live on ! Find out more
SYRE icon

Spyre Therapeutics

Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$31.9M
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$27.8M +$3.15M +18,017 +15%
BBA
3
Baker Bros. Advisors
New York
$27.1M
BlackRock
4
BlackRock
New York
$23.7M -$839K -4,799 -4%
BCLSI
5
Bain Capital Life Sciences Investors
Massachusetts
$22.6M +$1.03M +5,908 +5%
PAMS
6
Pictet Asset Management (Switzerland)
Switzerland
$20.1M +$17.7M +101,312 New
SCM
7
Suvretta Capital Management
New York
$17.2M +$445K +2,545 +3%
Vanguard Group
8
Vanguard Group
Pennsylvania
$16.8M +$81K +463 +0.6%
ACM
9
Aisling Capital Management
New York
$13.4M
RSCM
10
Rock Springs Capital Management
Maryland
$12.5M
NCM
11
Nantahala Capital Management
Connecticut
$12.1M -$1.12M -6,403 -10%
Goldman Sachs
12
Goldman Sachs
New York
$9.03M +$35K +200 +0.4%
AG
13
Artal Group
Luxembourg
$8.31M
GPP
14
Great Point Partners
Connecticut
$7.16M
SB
15
Samsara BioCapital
California
$7.03M
State Street
16
State Street
Massachusetts
$6.1M +$66.1K +378 +1%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$5.49M +$85.9K +491 +2%
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$5.03M +$201K +1,149 +5%
ACM
19
Altium Capital Management
New York
$4.85M
LCM
20
Laurion Capital Management
New York
$4.82M +$4.24M +24,266 New
Millennium Management
21
Millennium Management
New York
$4.25M -$55.6K -318 -1%
SCM
22
Sio Capital Management
New York
$3.55M +$303K +1,734 +11%
Axa
23
Axa
France
$3.5M +$107K +613 +4%
Northern Trust
24
Northern Trust
Illinois
$2.91M -$18.5K -106 -0.7%
Marshall Wace
25
Marshall Wace
United Kingdom
$2.51M -$2.35M -13,423 -52%